Clinical trial Recruiting at 1 site Observational Ages 18 and up

Effects of nasal ventilation on brain and lung function in intubated patients

Official title: Effects of Nasal Ventilation on Cerebral and Pulmonary Function in Orally Intubated Patients

Run by Assistance Publique - Hôpitaux de Paris · NCT06438302 · Data updated 2026-11-12

This study tests how using nasal ventilation affects brain and lung function in patients who are intubated due to severe breathing problems.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment22 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedJanuary 31, 2025
Main results expectedFebruary 1, 2028
Study endsFebruary 1, 2028
Registry record updatedDecember 3, 2025
Trial IDNCT06438302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with hypoxemic acute respiratory failure who have been intubated for less than four days.

Probably not a fit

Patients with central nervous system diseases, psychiatric illnesses, or hemodynamic instability may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how nasal ventilation impacts cerebral and pulmonary function in patients who are orally intubated due to hypoxemic acute respiratory failure. It aims to evaluate the modulation of brain activity and tissue oxygenation through the application of humidified nasal airflow at varying rates. The study will measure electroencephalogram (EEG) activity and assess changes in cerebral perfusion, oxygenation, and regional pulmonary ventilation under different conditions. The findings could provide insights into the importance of nasal ventilation in improving outcomes for intubated patients.

Why it matters

Potential benefit: If successful, this study could enhance the management of intubated patients by improving brain activity and pulmonary function through nasal ventilation.

How similar studies have gone: While the specific approach of this study may be novel, similar studies have indicated that nasal ventilation can positively influence respiratory and cognitive outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years old
2. Hypoxemic acute respiratory failure
3. Intubation and mechanical ventilation since less than 4 days
4. PaO2/FiO2 ratio less than 200
5. RASS\<-4
6. Consent obtained from next of kin
7. Patient with health insurance

Exclusion Criteria:

1. Central nervous system diseases (stroke, MS, epilepsy)
2. Psychiatric illnesses (psychosis, depression) (indicated on patient's medical record)
3. Hemodynamic instability (noradrenalin\>2mg/h)
4. Patient on AME
5. Patients under legal protection (guardianship/curators)
6. Pregnant or breast-feeding women

Where it's running

  • Service de Médecine Intensive Réanimation - Hôpital Pitié -Salpêtrière
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.